Literature DB >> 3416339

Distribution and ontogeny of VIP-like immunoreactivity in the gastro-entero-pancreatic system of a cartilaginous fish Scyliorhinus stellaris.

G Tagliafierro1, E Bonini, G Faraldi, L Farina, G G Rossi.   

Abstract

The presence, distribution and development of vasoactive intestinal polypeptide (VIP)-like immunoreactivity in the gastro-entero-pancreatic system of a cartilaginous fish Scyliorhinus stellaris (L.) was investigated by immunohistochemical methods utilizing mammalian VIP antisera. In the gut VIP-like immunoreactivity was observed in both nerves and endocrine cells. Endocrine cells with VIP-like material were only detected in the intestinal epithelium while nerve fibres containing VIP-like material were noted along the whole gastro-entero-pancreatic system, being more numerous in the pyloric sphincter and in the intestinal portion. Immunoreactive nerve cell bodies were encountered in the stomach and intestinal portions localized in the submucosa and in the myenteric plexus. Intestinal immunoreactive endocrine cells were already present in the first developmental stage considered (embryos aged 4 months). They grow in number and before birth reach a frequency higher than in adults. Nerves and cell bodies showing VIP-like immunoreactivity, appear later, before birth, as a few elements in the smooth muscular layer, but only after birth their distribution and frequency are similar to those found in adults. The faint immunofluorescence shown by the immunoreactive endocrine cells and their developmental pattern, which is always different from that observed in nervous elements, suggest the presence of at least two VIP-like substances in the gastro-entero-pancreatic system of S. stellaris.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3416339     DOI: 10.1007/BF00221735

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  32 in total

1.  Ontogeny of peptide-producing nerves and endocrine cells of the gastro-duodeno-pancreatic region.

Authors:  L I Larsson
Journal:  Histochemistry       Date:  1977-10-22

2.  Isolation and partial sequence of elasmobranch VIP.

Authors:  R Dimaline; M C Thorndyke; J Young
Journal:  Regul Pept       Date:  1986-03

3.  Simultaneous localization of multiple tissue antigens using the peroxidase-labeled antibody method: a study on pituitary glands of the rat.

Authors:  P K Nakane
Journal:  J Histochem Cytochem       Date:  1968-09       Impact factor: 2.479

4.  An endogenous peptide stimulates secretory activity in the elasmobranch rectal gland.

Authors:  T J Shuttleworth; M C Thorndyke
Journal:  Science       Date:  1984-07-20       Impact factor: 47.728

5.  Vasoactive intestinal polypeptide-like immunoreactivity in nerves of the pancreatic islet of the teleost fish, Gillichthys mirabilis.

Authors:  S Van Noorden; G J Patent
Journal:  Cell Tissue Res       Date:  1980       Impact factor: 5.249

6.  Development of intestinal regulatory peptides in the human fetus.

Authors:  M G Bryant; A M Buchan; M Gregor; M A Ghatei; J M Polak; S R Bloom
Journal:  Gastroenterology       Date:  1982-07       Impact factor: 22.682

7.  Biochemical and physiological studies on peptides from the elasmobranch gut.

Authors:  M C Thorndyke; T J Shuttleworth
Journal:  Peptides       Date:  1985       Impact factor: 3.750

8.  Bombesin-, gastrin/CCK-, 5-hydroxytryptamine-, neurotensin-, somatostatin-, and VIP-like immunoreactivity and catecholamine fluorescence in the gut of the elasmobranch, Squalus acanthias.

Authors:  S Holmgren; S Nilsson
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

9.  Vasoactive intestinal polypeptide (VIP) in epithelial cells of the gut mucosa of an elasmobranchian cartilaginous fish, the ray.

Authors:  S Falkmer; J Fahrenkrug; J Alumets; R Håkanson; F Sundler
Journal:  Endocrinol Jpn       Date:  1980-12

10.  Haemodynamic effects of secretory agents on the isolated elasmobranch rectal gland.

Authors:  T J Shuttleworth
Journal:  J Exp Biol       Date:  1983-03       Impact factor: 3.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.